HWM
AMPH icon

Hohimer Wealth Management’s Amphastar Pharmaceuticals AMPH Stock Holding History

Hohimer Wealth Management’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$256K Buy
+13,066
New +$320K 0.03% 258
2025
Q4 		– Sell
-11,972
Closed -$319K – 321
2025
Q3 		$319K Buy
11,972
+127
+1% +$3.28K 0.04% 222
2025
Q2 		$272K Buy
11,845
+3,840
+48% +$95.3K 0.05% 189
2025
Q1 		$232K Buy
8,005
+520
+7% +$16.6K 0.05% 223
2024
Q4 		$278K Buy
7,485
+491
+7% +$22.5K 0.05% 187
2024
Q3 		$339K Buy
+6,994
New +$307K 0.07% 159

Other funds holding AMPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return

Hohimer Wealth Management's AMPH Position: Q1 2026 in Review

Hohimer Wealth Management opened a new position in Amphastar Pharmaceuticals (AMPH) in Q1 2026: 13,066 shares worth $256K. The stake represents 0.03% of the portfolio and ranks #258 among its holdings. This is a return to the name: Hohimer Wealth Management previously reported a position in AMPH as recently as Q3 2025.

Hohimer Wealth Management first reported a position in AMPH in Q3 2024 and has held it in 6 quarters since. The position peaked at $339K in Q3 2024. 215 funds tracked by Wall St. Rank hold AMPH as of Q1 2026.

  • Hohimer Wealth Management held 13,066 shares of Amphastar Pharmaceuticals worth $256K as of Q1 2026.
  • Amphastar Pharmaceuticals was a new Hohimer Wealth Management position in Q1 2026.
  • Amphastar Pharmaceuticals made up 0.03% of Hohimer Wealth Management's portfolio in Q1 2026, its #258 holding.
  • Hohimer Wealth Management first reported a position in Amphastar Pharmaceuticals in Q3 2024 and has held it in 6 quarters since.
  • Hohimer Wealth Management's Amphastar Pharmaceuticals position peaked at $339K in Q3 2024.
  • 215 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2026.

Based on Hohimer Wealth Management's 13F filing for Q1 2026, filed 1 May 2026.